 Pliant Therapeutics Inc NASDAQ: PLRX shares are trading lower Tuesday after the company announced a proposed 150 million offering. Pliant Therapeutics shares soared by nearly 160 Monday on the companys treatment for Idiopathic Pulmonary Fibrosis, which was. 